| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12094-017-1621-6 |
| P698 | PubMed publication ID | 28160206 |
| P2093 | author name string | L Ma | |
| X Xiang | |||
| Y-Y Wang | |||
| B-D Xiang | |||
| J-H Zhong | |||
| L-Q Li | |||
| X-M You | |||
| P2860 | cites work | A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma | Q24544663 |
| Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis | Q26798872 | ||
| Management of hepatocellular carcinoma: An update | Q27860530 | ||
| EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 | ||
| Hepatocellular carcinoma | Q29615765 | ||
| Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 | ||
| Hepatocellular carcinoma: clinical frontiers and perspectives | Q35112053 | ||
| Herbal medicine and hepatocellular carcinoma: applications and challenges | Q35117008 | ||
| Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion | Q36151948 | ||
| Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma. | Q36194426 | ||
| Immunological landscape and immunotherapy of hepatocellular carcinoma | Q38611895 | ||
| Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study | Q38845317 | ||
| Epidemiological analysis of primary liver cancer in the early 21st century in Guangxi province of China | Q39930605 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Surveillance for hepatocellular carcinoma: in whom and how? | Q42593959 | ||
| The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients | Q44526552 | ||
| Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. | Q44885846 | ||
| The STORM trial and beyond: narrowing the horizon of adjuvant sorafenib for postoperative hepatocellular carcinoma. | Q53300584 | ||
| Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma. | Q53340858 | ||
| Trend of improving prognosis of hepatocellular carcinoma in clinical practice: an Italian in-field experience. | Q53391931 | ||
| Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma | Q59203691 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 891-897 | |
| P577 | publication date | 2017-02-03 | |
| P1433 | published in | Clinical and Translational Oncology | Q15754324 |
| P1476 | title | Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma | |
| P478 | volume | 19 |
| Q92135518 | A machine learning model to predict hepatocellular carcinoma response to transcatheter arterial chemoembolization |
| Q55134101 | Expression of HSP90AA1/HSPA8 in hepatocellular carcinoma patients with depression. |
| Q33805289 | New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus |
| Q49732572 | Prognostic value of PD -L1 expression in patients with primary solid tumors |
| Q91928496 | Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study |
Search more.